|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/7125 | |||
| A61P 3/06 |
| (11) | Patento numeris | 3011028 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14813192.3 |
| Europos patento paraiškos padavimo data | 2014-06-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-04-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-06-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/043731 |
| Data | 2014-06-23 |
| (87) | Numeris | WO 2014/205451 |
| Data | 2014-12-24 |
| (30) | Numeris | Data | Šalis |
| 201361838190 P | 2013-06-21 | US | |
| 201361871683 P | 2013-08-29 | US |
| (72) |
PRAKASH, Thazha, P., US
LIMA, Walter, F., US
KINBERGER, Garth, A., US
MURRAY, Heather, US
SWAYZE, Eric, E., US
CROOKE, Stanley, T., US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | COMPOSITIONS AND METHODS FOR MODULATION OF TARGET NUCLEIC ACIDS |
| COMPOSITIONS AND METHODS FOR MODULATION OF TARGET NUCLEIC ACIDS |